Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Pfizer's HYMPAVZI gets European Commission Approval to Treat Severe Hemophilia A and B

Farhat Nasim21 Nov 2024 3:26 PM IST

Delhi: Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for Hympavzi (marstacimab) for the routine...

Strides Pharma Secures NCLT Approval for OneSource, India's First Specialty Pharma CDMO

Farhat Nasim21 Nov 2024 1:56 PM IST

Mumbai: Strides Pharma Science Limited, on Tuesday, announced that the National Company Law Tribunal (NCLT), Mumbai Bench, has approved its Scheme of...

Sun Pharma, Alembic and 1 other recall products

Cipla Recalls Lanthanum Carbonate Tablets in US

Farhat Nasim21 Nov 2024 1:38 PM IST

As per the USFDA, New Jersey based Cipla USA, Inc is recalling the affected lot due to "complaints received of crushed and broken tablets".

Fire Destroys Primary Health Centre in Nidmanoor

Hyderabad Pharma Plant Explosion Leaves 1 Dead, 3 Injured

Farhat Nasim21 Nov 2024 1:24 PM IST

Hyderabad: In an unfortunate incident, a chemical reactor explosion at Aurore Pharmaceuticals Private Ltd in Hyderabad claimed life of a worker, while...

Abiogenesis Clinpharm To Conduct Phase III Trial of UTI Drug Phenazopyridine

Sage Therapeutics' Experimental Drug for Huntington's Disease Fails Mid-Stage Trial

Farhat Nasim21 Nov 2024 11:30 AM IST

The drug, dalzanemdor, did not significantly improve cognitive function in patients compared to placebo after 84 days, failing to meet the main goal

NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP Uniformity

NPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details

Farhat Nasim20 Nov 2024 4:08 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for six drug formulations following review orders...

Lupin to Conduct BE Study for Synthetic Semaglutide Tablets in 3 Strengths

Lupin's generic drug to treat ADHD symptoms gets USFDA approval

Farhat Nasim20 Nov 2024 2:57 PM IST

Mumbai: Lupin Limited announced on Tuesday that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck's Injectable Keytruda Proves Effective in Trial, Promises Easier Cancer Treatment

Farhat Nasim20 Nov 2024 2:01 PM IST

Merck was testing the injectable version of the world's biggest selling drug in a late stage trial of patients with a type of lung cancer.

Unichem Labs Roha facility gets 3 USFDA observations

USFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility

Farhat Nasim20 Nov 2024 1:48 PM IST

New Delhi: Dr Reddy's Laboratories Ltd on Tuesday said the US health regulator has issued a Form 483 with seven observations to its active...

Novo Nordisk Launches Wegovy in South Africa, Ramping Up Obesity Drug Battle with Eli Lilly

Novo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients

Farhat Nasim20 Nov 2024 1:36 PM IST

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has yet to launch it.

Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update

Eli Lilly's Experimental Drug Muvalaplin Lowers Inherited Cholesterol by Up to 86 percent

Farhat Nasim20 Nov 2024 1:05 PM IST

Ruth Gimeno, Lilly's group vice president for diabetes and metabolic research, said Eli Lilly is weighing next steps for advancing to late stage...

Lupin, Avas launch myotonia treatment NaMuscla in Italy

Lupin launches generic equivalent of Bumex Injection in US

Farhat Nasim20 Nov 2024 12:43 PM IST

Mumbai: Global pharma major Lupin Limited (Lupin) announced on Tuesday the launch of Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok